Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meso Scale Discovery develops and commercializes highly sensitive multiplex immunoassay platforms based on proprietary electrochemiluminescence detection. Their MULTI‑ARRAY technology enables simultaneous quantification of multiple biomarkers from small sample volumes with high sensitivity and reproducibility. Widely adopted by pharmaceutical companies, academic labs, government agencies, and clinical researchers worldwide to accelerate drug discovery and translational medicine efforts. The company continues to expand its offerings into clinical diagnostics and personalized medicine applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meso Scale Discovery.